e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Sun Life Financial
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TCGX Acquisition Corp. - Class A Ordinary Shares
(NQ:
TCGX
)
10.02
-0.01 (-0.05%)
Delayed Quote
Updated: 3:59 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about TCGX Acquisition Corp. - Class A Ordinary Shares
TriGemX Bio Appoints Daniel Lynch as Chairman of the TriGemX Bio Board of Directors
November 09, 2026
From
TriGemX Bio, Inc.
Via
Business Wire
TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
November 02, 2026
From
TCGX Acquisition Corp.
Via
Business Wire
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine
October 19, 2026
From
TCGX Acquisition Corp.
Via
Business Wire
TCGX Acquisition Corp. Announces Completion of its Initial Public Offering
August 06, 2026
From
TCGX Acquisition Corp.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.